Merck's Keytruda wins FDA approval as combination therapy for kidney cancer

France Nouvelles Nouvelles

Merck's Keytruda wins FDA approval as combination therapy for kidney cancer
France Dernières Nouvelles,France Actualités
  • 📰 Reuters
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 97%

The U.S. Food and Drug Administration has approved Merck & Co Inc's cancer ...

FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid

The drug was approved in combination with Pfizer Inc’s Inlyta to treat advanced renal cell carcinoma. The Keytruda/Inlyta combination could provide serious competition for Bristol-Myers Squibb Co’s immunotherapy combination of Opdivo and Yervoy, currently considered a gold standard for previously untreated advanced kidney cancer patients.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

Reuters /  🏆 2. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

‘People will try to stop you’: Merck CEO Kenneth Frazier told us the inside story of how a janitor’s son rose to graduate from Harvard Law and lead the $210 billion US pharma giant Merck‘People will try to stop you’: Merck CEO Kenneth Frazier told us the inside story of how a janitor’s son rose to graduate from Harvard Law and lead the $210 billion US pharma giant MerckKenneth Frazier, the 64-year-old CEO of US drug giant Merck, grew up in a deeply unequal America, an experience that has shaped him profoundly.
Lire la suite »

Health-care stocks keep getting hammered — Wall Street says this is whyHealth-care stocks keep getting hammered — Wall Street says this is whyFour of the Dow Jones Industrial Average’s 10 biggest losers on Wednesday were health companies, including UnitedHealth Group Inc., Merck & Co. , Pfizer...
Lire la suite »

Nintendo shares jump 17 percent after Tencent wins key China Switch sales approvalNintendo shares jump 17 percent after Tencent wins key China Switch sales approvalNintendo Co Ltd shares jumped 17 percent in morning Tokyo trade on Friday, a day...
Lire la suite »

Egyptian President Sissi wins approval from lawmakers to stay in office until 2030Egyptian President Sissi wins approval from lawmakers to stay in office until 2030Egypt’s parliament voted for sweeping changes in the country’s constitution to extend President Abdel Fatah al-Sissi’s rule and give him unprecedented powers.
Lire la suite »

Diabetes drug may prevent, slow kidney disease, study findsDiabetes drug may prevent, slow kidney disease, study findsInvokana, a drug that’s used to help control blood sugar in people with diabetes, may also help thousands of people who require dialysis.
Lire la suite »

A win for Trump in 2020 would be a win for stocks, says Nobel-winning economistA win for Trump in 2020 would be a win for stocks, says Nobel-winning economistFrom gilded penthouses and fancy cars to big yachts and oversized Brioni suits, Donald Trump’s penchant for spending is the stuff of legends. And it could...
Lire la suite »

Analysis | Pence, Buttigieg and the debate over ‘conversion therapy’Analysis | Pence, Buttigieg and the debate over ‘conversion therapy’Democratic hopeful Pete Buttigieg's attacks on Vice President Pence have again raised claims that the vice president once backed 'conversion therapy.'
Lire la suite »

Study: Researchers successfully treat babies with 'bubble boy' disease using gene therapyStudy: Researchers successfully treat babies with 'bubble boy' disease using gene therapyResearchers from St. Jude Children’s Research Hospital have cured babies with “bubble boy” disease through gene therapy involving a re-engineered virus.
Lire la suite »

Babies with 'bubble boy disease' cured using HIV in gene therapyBabies with 'bubble boy disease' cured using HIV in gene therapyBabies with 'bubble boy disease' cured using gene therapy made from one of the immune system's worst enemies — HIV, the virus that causes AIDS. - NBCNewsHealth
Lire la suite »

Gene therapy cures infants with ‘bubble boy’ immune diseaseGene therapy cures infants with ‘bubble boy’ immune diseaseGene therapy cures infants with 'bubble boy' immune disorder, raising hopes of using it to remedy other genetic diseases
Lire la suite »



Render Time: 2025-03-10 10:28:12